Roberto Iacovelli, MD, PhD, is a medical oncologist at the Fondazione Policlinico Gemelli IRCCS in Rome, Italy, a major Italian national hospital with more than 1,500 beds and an active comprehensive cancer centre. He studied medicine at the “Sapienza” University of Rome, following which he specialized in medical oncology at the same university and earned a PhD in molecular medicine and human pathology with a focus on genitourinary cancers. He gained international experience as fellow at the Gustave Roussy Institute in Paris, France, and worked as an oncologist in the main oncological referral centres in Italy.
Dr Iacovelli’s research activities focus on metastatic renal cell carcinoma, prostate cancer, and bladder cancer. His major interest is in predictive and prognostic factors in genitourinary (GU) cancers, as well as the sequence of therapy in renal cancer and the new combination of therapies in GU tumours. He has participated as Principal Investigator or sub-investigator in many sponsored and academic clinical trials.
Dr Iacovelli has published more than 150 papers in international peer-reviewed journals and several abstracts at international conferences. He has received many national and international awards, such as the American Society of Clinical Oncology (ASCO) Cancer Foundation Merit Award in 2011 and the Best Poster Award at the European Society for Medical Oncology (ESMO) Congress 2012; he is currently a member of the Italian committee for guidelines in GU tumours.
Date of preparation: April 2020